Chinese Traditional and Herbal Drugs
|
2025, 56(11): 3966-3973
Efficacy and safety of Jingfang Mixture in treatment of urticaria: A randomized, double-blind, positive parallel controlled clinical trial
Full
ZHANG Huina, CHENG Yu, SUN Liyun, ZHAO Guowei, LI Mei, ZHOU Dongmei
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.11.017
Outline
Objective To explore the efficacy and safety of Jingfang Mixture (荆防合剂) in treatment of urticaria, with cetirizine hydrochloride tablets as the control. Method A total of 72 patients with clinically diagnosed spontaneous urticaria who met the inclusion criteria outlined in the study protocol, were randomly assigned to either the treatment group or the control group at a 1∶1 ratio, with 36 participants in each group. The treatment group received Jingfang Mixture orally, two vials three times daily, while the control group took cetirizine hydrochloride tablets orally at one tablet once daily or half tablet twice daily in the morning and evening. The treatment course lasted 14 days, with follow-ups conducted on the 7th and 14th days of the treatment respectively. After the treatment of the two groups, efficacy and safety were evaluated by comparing the urticaria activity score over 7 days (UAS7), proportion of subjects with UAS7 < 7, urticaria symptom disappearance time, dermatology life quality index (DLQI), and symptom score reduction index (SSRI) between the groups. Result After the treatment, there was no significant difference in the cure rate and total effective rate between the two groups (P > 0.05). There was no statistically significant difference in the 7-day urticaria activity score between the two groups (P > 0.05). on the 7th day, the proportion of subjects with UAS7 < 7 in the experimental group and the control group was 15.63% and 48.57%, respectively, and the difference between the groups was statistically significant (P < 0.05); On the 14th day, with no statistically significant difference between the groups (P > 0.05). The disappearance time of urticaria symptoms (itching, wheals) in the experimental group and control group within 14 days of medication was (10.2 ± 3.62) d and (10.6 ± 4.83) d, respectively, with no statistically significant difference between the groups (P > 0.05). On the 14th day after taking the medication, the number of subjects in the experimental group and the control group whose urticaria symptoms (itching, wheals) disappeared (disappearance rate) were 16 cases (64.00%) and 16 cases (53.33%), respectively, with no statistically significant difference between the groups (P > 0.05). On the 7th and 14th day after medication, there were statistically significant differences (P < 0.05) in the dermatology quality of life index (DLQI) between the experimental group and the control group compared to baseline, while there was no statistically significant difference (P > 0.05) between the groups. the SSRI of the experimental group and the control group were 84.27 ± 26.00 and 68.68 ± 40.68, respectively, with no statistically significant difference between the groups (P > 0.05). No serious adverse events occurred in this study. Conclusion The overall efficacy of Jingfang Mixture is comparable to that of cetirizine hydrochloride tablets. Moreover, the drug has good safety and is worthy of clinical promotion and application.
urticaria
/
Jingfang Mixture
/
itching symptoms
/
UAS7
/
DLQI
张会娜, 成玉, 孙丽蕴, 赵国伟, 李梅, 周冬梅.
荆防合剂治疗荨麻疹的有效性和安全性随机、双盲、阳性药平行对照临床试验.
中草药,
2025
, 56
(11)
: 3966
-3973
.
DOI: 10.7501/j.issn.0253-2670.2025.11.017
ZHANG Huina, CHENG Yu, SUN Liyun, ZHAO Guowei, LI Mei, ZHOU Dongmei.
Efficacy and safety of Jingfang Mixture in treatment of urticaria: A randomized, double-blind, positive parallel controlled clinical trial[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(11)
: 3966
-3973
.
DOI: 10.7501/j.issn.0253-2670.2025.11.017
Year 2025 volume 56 Issue 11
53
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.11.017
- Receive Date:2025-03-11
- Online Date:2026-11-13